238 related articles for article (PubMed ID: 33432327)
1. Loss of sarcospan exacerbates pathology in mdx mice, but does not affect utrophin amelioration of disease.
Gibbs EM; McCourt JL; Shin KM; Hammond KG; Marshall JL; Crosbie RH
Hum Mol Genet; 2021 Apr; 30(3-4):149-159. PubMed ID: 33432327
[TBL] [Abstract][Full Text] [Related]
2. Dystrophin and utrophin expression require sarcospan: loss of α7 integrin exacerbates a newly discovered muscle phenotype in sarcospan-null mice.
Marshall JL; Chou E; Oh J; Kwok A; Burkin DJ; Crosbie-Watson RH
Hum Mol Genet; 2012 Oct; 21(20):4378-93. PubMed ID: 22798625
[TBL] [Abstract][Full Text] [Related]
3. Stabilization of the cardiac sarcolemma by sarcospan rescues DMD-associated cardiomyopathy.
Parvatiyar MS; Brownstein AJ; Kanashiro-Takeuchi RM; Collado JR; Dieseldorff Jones KM; Gopal J; Hammond KG; Marshall JL; Ferrel A; Beedle AM; Chamberlain JS; Renato Pinto J; Crosbie RH
JCI Insight; 2019 Apr; 5(11):. PubMed ID: 31039133
[TBL] [Abstract][Full Text] [Related]
4. Sarcospan integration into laminin-binding adhesion complexes that ameliorate muscular dystrophy requires utrophin and α7 integrin.
Marshall JL; Oh J; Chou E; Lee JA; Holmberg J; Burkin DJ; Crosbie-Watson RH
Hum Mol Genet; 2015 Apr; 24(7):2011-22. PubMed ID: 25504048
[TBL] [Abstract][Full Text] [Related]
5. Multi-omics analysis of sarcospan overexpression in mdx skeletal muscle reveals compensatory remodeling of cytoskeleton-matrix interactions that promote mechanotransduction pathways.
McCourt JL; Stearns-Reider KM; Mamsa H; Kannan P; Afsharinia MH; Shu C; Gibbs EM; Shin KM; Kurmangaliyev YZ; Schmitt LR; Hansen KC; Crosbie RH
Skelet Muscle; 2023 Jan; 13(1):1. PubMed ID: 36609344
[TBL] [Abstract][Full Text] [Related]
6. Sarcospan reduces dystrophic pathology: stabilization of the utrophin-glycoprotein complex.
Peter AK; Marshall JL; Crosbie RH
J Cell Biol; 2008 Nov; 183(3):419-27. PubMed ID: 18981229
[TBL] [Abstract][Full Text] [Related]
7. High levels of sarcospan are well tolerated and act as a sarcolemmal stabilizer to address skeletal muscle and pulmonary dysfunction in DMD.
Gibbs EM; Marshall JL; Ma E; Nguyen TM; Hong G; Lam JS; Spencer MJ; Crosbie-Watson RH
Hum Mol Genet; 2016 Dec; 25(24):5395-5406. PubMed ID: 27798107
[TBL] [Abstract][Full Text] [Related]
8. High-throughput screening identifies modulators of sarcospan that stabilize muscle cells and exhibit activity in the mouse model of Duchenne muscular dystrophy.
Shu C; Parfenova L; Mokhonova E; Collado JR; Damoiseaux R; Campagna J; John V; Crosbie RH
Skelet Muscle; 2020 Sep; 10(1):26. PubMed ID: 32948250
[TBL] [Abstract][Full Text] [Related]
9. Sarcospan increases laminin-binding capacity of α-dystroglycan to ameliorate DMD independent of Galgt2.
Mamsa H; Stark RL; Shin KM; Beedle AM; Crosbie RH
Hum Mol Genet; 2022 Mar; 31(5):718-732. PubMed ID: 34581784
[TBL] [Abstract][Full Text] [Related]
10. Enhanced expression of the alpha 7 beta 1 integrin reduces muscular dystrophy and restores viability in dystrophic mice.
Burkin DJ; Wallace GQ; Nicol KJ; Kaufman DJ; Kaufman SJ
J Cell Biol; 2001 Mar; 152(6):1207-18. PubMed ID: 11257121
[TBL] [Abstract][Full Text] [Related]
11. Identification of FHL1 as a therapeutic target for Duchenne muscular dystrophy.
D'Arcy CE; Feeney SJ; McLean CA; Gehrig SM; Lynch GS; Smith JE; Cowling BS; Mitchell CA; McGrath MJ
Hum Mol Genet; 2014 Feb; 23(3):618-36. PubMed ID: 24087791
[TBL] [Abstract][Full Text] [Related]
12. Development of a high-throughput screen to identify small molecule enhancers of sarcospan for the treatment of Duchenne muscular dystrophy.
Shu C; Kaxon-Rupp AN; Collado JR; Damoiseaux R; Crosbie RH
Skelet Muscle; 2019 Dec; 9(1):32. PubMed ID: 31831063
[TBL] [Abstract][Full Text] [Related]
13. Sarcospan Regulates Cardiac Isoproterenol Response and Prevents Duchenne Muscular Dystrophy-Associated Cardiomyopathy.
Parvatiyar MS; Marshall JL; Nguyen RT; Jordan MC; Richardson VA; Roos KP; Crosbie-Watson RH
J Am Heart Assoc; 2015 Dec; 4(12):. PubMed ID: 26702077
[TBL] [Abstract][Full Text] [Related]
14. Sarcolemmal nNOS anchoring reveals a qualitative difference between dystrophin and utrophin.
Li D; Bareja A; Judge L; Yue Y; Lai Y; Fairclough R; Davies KE; Chamberlain JS; Duan D
J Cell Sci; 2010 Jun; 123(Pt 12):2008-13. PubMed ID: 20483958
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of dystrophin and utrophin gene transfer in immunocompetent muscular dystrophy (mdx) mice.
Ebihara S; Guibinga GH; Gilbert R; Nalbantoglu J; Massie B; Karpati G; Petrof BJ
Physiol Genomics; 2000 Sep; 3(3):133-44. PubMed ID: 11015608
[TBL] [Abstract][Full Text] [Related]
16. Embryonic myosin is a regeneration marker to monitor utrophin-based therapies for DMD.
Guiraud S; Edwards B; Squire SE; Moir L; Berg A; Babbs A; Ramadan N; Wood MJ; Davies KE
Hum Mol Genet; 2019 Jan; 28(2):307-319. PubMed ID: 30304405
[TBL] [Abstract][Full Text] [Related]
17. Sub-physiological sarcoglycan expression contributes to compensatory muscle protection in mdx mice.
Li D; Long C; Yue Y; Duan D
Hum Mol Genet; 2009 Apr; 18(7):1209-20. PubMed ID: 19131360
[TBL] [Abstract][Full Text] [Related]
18. Characterization of neuromuscular synapse function abnormalities in multiple Duchenne muscular dystrophy mouse models.
van der Pijl EM; van Putten M; Niks EH; Verschuuren JJ; Aartsma-Rus A; Plomp JJ
Eur J Neurosci; 2016 Jun; 43(12):1623-35. PubMed ID: 27037492
[TBL] [Abstract][Full Text] [Related]
19. Microutrophin delivery through rAAV6 increases lifespan and improves muscle function in dystrophic dystrophin/utrophin-deficient mice.
Odom GL; Gregorevic P; Allen JM; Finn E; Chamberlain JS
Mol Ther; 2008 Sep; 16(9):1539-45. PubMed ID: 18665159
[TBL] [Abstract][Full Text] [Related]
20. Expression of a NOS transgene in dystrophin-deficient muscle reduces muscle membrane damage without increasing the expression of membrane-associated cytoskeletal proteins.
Tidball JG; Wehling-Henricks M
Mol Genet Metab; 2004 Aug; 82(4):312-20. PubMed ID: 15308129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
